Protective Effect of Folic Acid against Apoptosis Induced by Ischemia/Reperfusion Injury in Rat Liver

Document Type: Research Paper


1 College of Pharmacy IFTM , Lodhipur Rajput Moradabad-244001U.P. India Pharmacy Group, Birla Institute of Technology and Sciences, Pilani -333031 Rajasthan, India

2 Division of Pathology, Indian Veterinary Research Institute Izatnagar-243122, UP, India

3 Division of Bacteriology, National Biotechnology Centre Indian Veterinary Research Institute Izatnagar-243122, UP, India

4 College of Pharmacy IFTM , Lodhipur Rajput Moradabad-244001U.P. India


       The anti-apoptotic gene bcl-2 is located in mitochondria, but it is uncertain whether its expression affects hepatocyte survival in ischemia/reperfusion (I/R) injury. This experiment was designed to evaluate the role of folic acid in expression of bcl-2 in I/R in rat liver. Eighteen Wister rats were divided into sham-operated controlgroup (C) (n=6), I/R group (n=6), folic acid treated group which received 1 mg/kg/day folic acid by oral route for 7 days before induction of I/R (n=6). Bcl-2 expression was measured by RT-PCR and western blot methods. Folic acid significantly increased Bcl-2 mRNA expression in comparison to the I/R group. Quantification of apoptotic and necrotic hepatocytes, measured by fluorescence microscopy and terminal deoxynucleotidyl transferase (TdT)-mediated dUDP-biotin nick end labeling (TUNEL) method, showed a significant decrease in apoptosis and necrosis of hepatocytes in folic acid-treated group. Histopathologi-cal examination of the liver revealed that folic acid protected from severe hepatic degeneration from I/R injury. The biochemical parameters like alanine transaminases and aspartate transaminases were significantly decreased in folic acid-treated group compared to I/R group. In conclusion, folic acid afforded significant protection against I/R injury due to its ability to inhibit I/R-induced apoptosis.


1. Introduction

      Temporary clamping of the portal triad is a common strategy to minimize bleeding during hepatic resection. Unfortunately, this method resulted in hepatic ischemia-reperfusion (I/R) injury and may cause postoperative functional disorder of the liver. Development of new strategies to attenuate hepatic I/R injury is important for achieving a better clinical outcome. Recently, apoptosis and cell atrophy have been indicated as an important mode of cell death during hepatic I/R injury [1]. Apoptosis is governed by a number of regulating genes, such as bcl-2 whose expression determines survival or death following an apoptotic stimulus [2]. Overexpression of bcl-2 gene by transferring this gene into hepatocytes with adenovirus increases resistance to hepatic I/R injury [3]. Folate is a cofactor in 1-carbon metabolism, during which it promotes remethylation of homocysteine. In addition to augmenting the risk of vascular events, low folate/high homocysteine may directly increase the susceptibility of neurons to brain injury [4]. Folate deficiency causes uracil misincorpora-tion into DNA and chromosomal breakage, which has implications for neuronal damage [5-7]. In the present study, we have analyzed the affects of folic acid supplementation in sinusoidal reperfusion and apoptosis under defined surgical techniques i.e. portal triad clamping (Pringle manoeuvere).


2. Materials and methods

2.1. Animals and treatment

      Male Wister rats weighing 200 to 250 g were purchased from Laboratory Animal Resources, Indian Veterinary Research Institute, Izzatnagar, UP, India, and were maintained under temperature-controlled rooms at animal house, College of Pharmacy, IFTM, Moradabad, UP with 12 h alternating light and dark cycles. They were given nutrition and water ad libitum. All experimental protocols using animals were performed according to the "Principles of Laboratory Animal care" (NIH publication 85-23, revised 1985). Ischemia and reperfusion injury was induced according to the procedure described by Hayashi et al. [8]. The rats were divided into three groups with 6 animals in each group, and studies were performed after 3 h of reperfusion. The rats were divided into sham-operated control group (C), ischemia and reperfusion group (Group I), folic acid treated group (Group II) which received 1 mg/kg/day folic acid by oral route for 7 days before induction of I/R. After 3 h, the right atrium was punctured and blood was collected and stored with heparin at -8 °C. The blood was centrifuged and serum was separated and stored at -8 °C for biochemical analysis. The left and median lobes of the liver were removed and stored in 10% formalin for histopathological studies.


2.2. Biochemical analysis

      Blood was collected without any anticoagulant and the serum was separated. Serum samples were used for assay of alanine aminotransferase (ALT) [EC 2. 6. 1. 2], aspartate aminotransferase (AST) [EC 2. 6. 1. 1]. ALT and AST were measured by commercial Merck Kits.


Figure 1. bcl-2 gene expression. A: Representative photograph of the expression of bcl-2 gene using RT-PCR analysis. bcl-2 gene expressed at 234 bp and house keeping gene glyceraldehydes-3 phosphate dehydrogenase expressed at 510 bp. Lane M:Marker,  Lane 1: sham-operated control group, Lane 2: I/R, Lane 3:  Folic acid treated+I/R. B: The expression of  bcl-2 gene after 1 h of ischemia and 3 h of reperfusion . Data are expressed as the mean±SEM.


2.3. Reverse transcriptase polymerase chain reaction assay

      Total cytoplasmic RNA of each group was isolated from liver tissue by the TRIZOL method (according to GIBCO specification). Polymerase chain reaction (PCR) primers were against rat bcl-2 sequences obtained from gene bank (Fastaf). The sense primer was a 21-mer with a sequence of CGT-CAT-AAC-TAA-AGA-CAC-CCC, and the reverse primer was also a 21-mer with a sequence of TTC-ATC-TCC-AGT-ATC-CGA-CTC. The product length was 234 base pairs Tm of 52.3 °C. The cDNA was then amplified by PCR amplification with Ampli Taq Polymerase. The quality of cDNA was checked by PCR amplification of the house keeping gene encoding for glyceraldehydes-3-phosphate dehydrogenase. For PCR amplification, the reaction mixture contained 100 ng (2μl) of cDNA, 5μl 10 × PCR buffer, 1 μl 30 mM dNTP mix, 1 μl forward primer (100 ng/μl) and 1 μl reverse primer (100 ng/μl) and 0.5 U Ampli Taq polymerase, and final volume was adjusted to 50 μl. After heating to 94 °C for 7 min., DNA was subjected to 40 cycles of PCR by denaturing at 94 °C for 30s, annealing at 52.3 °C for 30s and extending at 72 °C for 1 min. The last cycle was followed by a 5 min. elongation step. Eighteen μl of amplified product was resolved by electrophoresis on 1.5% agarose gels, stained with ethidium bromide and visualized under ultraviolet light. A 1 kbp DNA ladder molecular weight marker (Life Technologies, Rockville, MD, USA) was run on every gel to confirm expected molecular weight of the amplification product. Bands were quantitatively measured by densitometry analysis system (Molecular Analyst/PC, Windows software for Bio-Rad's; Hercules, CA). Image Analysis System Version 1.5, and the data are expressed in relative optical density (OD) units.


2.4. Western blot analysis

     Cell lysates were prepared from liver and lysed in a buffer containing 1% Tritron X-100, 10 mM Tris buffer (pH=7.4), 150 mM NaCl, 2 mg/ml aprotinin and 10 mM phenylmethyl sulfonyl fluoride (PMSF). Protein samples (50 mg) were analyzed by sodium dodecyl sulphate (SDS) poly acrylamide gel elec-trophoresis (PAGE) under reducing condition transferred overnight to nylon membrane. Both were incubated with rabbit anti- mouse/rat bcl-2 primary antibody, followed by peroxides-labeled goat anti-rabbit secondary antibody and the bound antibodies were detected by enhanced chemiluminescences. Bands were quantitatively measured by densitometry analysis system (Molecular Analyst/PC, Windows software for Bio-Rad's; Hercules CA). Image Analysis System Version 1.5, and the data are expressed in relative optical density (OD) units.


Figure 2. The expression of bcl-2 protein. A: Representative photograph of the expression of bcl-2 protein using western blot analysis. Lane 1: Folic acid-treated ischemia and reperfused liver protein (group II). Lane 2: Sham-operated control group. Lane 3: Ischemic and reperfused liver protein (group I). B: The expression of bcl-2 protein after 1 h of ischemia and 3 h of reperfusion. Data are expressed as the mean±SEM.


2.5. In situ detection of cell death

     Liver apoptosis detected by TUNEL method. Specimens were dewaxed and immersed in phosphate-buffered saline containing 0.3% hydrogen peroxide for 10 min. at room temperature and then incubated with 20 mg/ml proteinase K for 15 min. Seventy-five μl of equilibration buffer were applied directly onto the specimens for 10 min. at room temperature, followed by 55 ml of TdT enzyme and then at 37 °C for 1 h. The reaction was terminated by transferring the slides to pre-warmed stop/wash buffer for 30 min. at 37 °C. The specimens were covered with a few drops of rabbit serum and incubated for 20 min. at room temperature and then covered with 55 ml of anti-digoxigenin peroxidase and incubated for 30 min. at room temperature. Specimens were then soaked in Tris buffer containing 0.02% diaminobenzidine and 0.02% hydrogen peroxide for 1 min. to achieve color development. Finally, the specimens were counterstained by immersion in hematoxylin. The cells with clear nuclear labeling were defined as TUNEL-positive cells.


2.6. Fluorescence microscopy

     Cells were washed with PBS and fixed with PBS-buffered (pH=7) 4% formaldehyde:1.5% methanol solution (CDH, Mumbai) at 4 °C for 15 min., then washed three times with PBS (Life Technologies, Inc.). Twenty five μl cells were taken in a PCR Tubes and 5 μl ethidium bromide (100 μl/ml) were added. Next, the cover slips were put on slides coated with buffered mounting medium consisting of 90% glycerol:10% PBS with 0.1% NaN3 and 3% DABCO (triethylenedi- amine; Sigma Chemical Co., St. Louis, MO), to prevent fading. Examination was done with inverted Zeiss confocal laser scanning microscope (LSM410; Carl Zeiss, Jena, Germany). For ethidium bromide, maximum excitation was performed by a 543-nm line of the internal He-Neon laser, and fluorescence emission was observed above 570 nm with longpass barrier filter LP-570. A water immersion objective, C-Apochromat 6331.2 W corr. (Zeiss), was used. Images were converted to TIFF format, and the contrast level and brightness of the images were adjusted by using the Zeiss LSM410 program.


Figure 3. Fluorescence microscopy of the liver cells. a: Nuclear morphological changes after IR injury.  Heavy DNA fragmentation and condensation are seen after staining with ethidum bromide (×40). b: Some DNA fragmentation and condensation is seen after staining with ethidium bromide in folic acid treated (×40). c: Some apoptotic DNA shows after staining with ethidium bromide in sham operated group (×40).


2.7. Histopathological evaluation light microscope assay

      Serial slices of liver tissues were prepared from rat in each group and stained with hematoxyline-eosin (HE) and then observed under light microscope at 200× or 400× magnification.


2.8. Transmission electron microscopy assay

     Liver tissue ware fixed in Karnovsky's solution pH 7.4 for 4 h at 4 °C and post-fixed with glutaraldehyde and osmium trioxide, respectively. Thick section were cut and stained with stained with toludine blue. Thin sections of 70 nm were stained with urayl acetate and lead citrate and viewed under Moragagni 268D electron microscopes (Netherlands).


2.9. Statistical analysis

     All values were expressed as mean±SEM. Differences in mean values were compared using SPSS 11.0 by one-way ANOVA and Student-Newman-Keul (SNK) test. A p < 0.05 was considered as statistically significant.


3. Results

3.1. Liver function tests

     Serum ALT and AST values were markedly increased by I/R (group I) compared to the sham-operated control group (C) (p < 0.05). Folic acid pre-treatment for 7 consecutive days (group II) markedly prevented the raise in serum ALT and AST levels induced by I/R (Table 1). Folic acid, therefore, protects liver tissue from I/R induced acute injury.


3.2. Semi quantitative RT-PCR analysis of apoptosis-related genes bcl-2 mRNA

     We investigated the expression of bcl-2 gene by RT-PCR method. The length of RT-PCR products of bcl-2 was 234 bp (Figure 1) and expression of bcl-2 gene in group I was lower compared to the sham-operated group after I/R. After treatment with folic acid (group II), the level of bcl-2 gene expression was significantly restored to near its level in sham-operated group after I/R (Figure 1). In group II, the amounts of bcl-2 mRNA transcript were markedly elevated in comparison with group I at matched times after reperfusion (p < 0.05).



Figure 4. Histopathology of rat liver. a: Fatty vacuolation degeneration, individualization or small clumps of hepatocytes in the centric-lobular hepatic cord disturbed observed in group I (I/R)  (H.E.× 400). b: Folic acid treated hepatocytes (group II) shows hepatic cord is well maintained and sinusoids are dilated (H.E.× 400).


Table 1. ALT and AST levels of liver in folic acid treated I/R injury, I/R injury and sham operated rats.


3.3. Western blot analysis of Bcl-2 protein bcl-2 protein was expressed at 25 kDA

      (Figure 2) and expressed lower level in group I compared to the sham-operated group after 1 h of ischemia and 3 h of reperfusion. After treatment with folic acid, the amount of expression of bcl-2 protein in group II was markedly increased in comparison to its level in group I.


3.4. Change of cellular apoptotic rates

     Apoptosis was measured by TUNEL assay. TUNEL-positive cells were detectable after I/R. The cellular apoptosis rate in group II was five times higher than in control group (Table 2). As shown in Table 2, administration of folic acid produced statistically significant decreases in the apoptosis rate compared to group I during I/R (p < 0.05).


3.5. Fluorescence microscopy

      Abnormal condenses nuclear fragmentation, membrane blabbing, cell shrinkage and apoptotic body were observed in I/R treated group (group I; Figure 3a). However, little condenses and some nuclear fragments were observed in folic acid treated group (Figure 3b) and exhibited normal structure similar to those of the sham operated group (Figure 3c).


3.6. Histopathological studies

     After I/R, swelling and fatty vacuolation, degeneration, individualization or small clumps of hepatocytes in the centric-lobular hepatic cord with cells showing several pyknotic condensed nuclei and cellular atrophy were found in hepatocytes of group I animals (Figure 4a). Folic acid-treated group showed normal structure of hepatocytes with well developed portal area. Hepatic cord and sinusoids were moderately conjugated. Compartment of hepatic sinus became dilated or disappeared along with little necrosis, atrophy and hemorrhage at I/R side was observed. Any pyknotic condensed nuclei were not observed, and centric lobular portion hepatic cord is well maintained (Figure 4b).


Figure 5. TEM analysis of liver sections following I/R. a: Group I liver section shows hepatocellular apoptosis with mitochondria were severely swollen and had a reduction in the number of cristae (5.0 K.E.X). b: Sham operated liver section shows normal architecture of cell. Prominent nucleus with well defined cell wall and cell membrane observed (7.0 K.E.X). c: Group II liver section shows structures similar to those of the sham group. Well defined nucleus with swollen mitochondria but no sign of apoptosis ( 5.0 K.E.X).


3.7. TEM analysis

     After 1 h of ischemia and 3 h of reperfusion in group I, mitochondria were severely swollen and had a reduction in the number of cristae. Smooth endoplasmic reticulum increased, glycogen granules decreased and nucleus was not well marked, and more secondary lysosomes were observed (Figure 5a). In group C, hepatocytes were observed only with prominent nucleus, and no abnormality was observed in cell (Figure 5b). In group II, mitochondria were moderately swollen and smooth endoplasmic reticulum and well marked nucleus were observed (Figure 5c).


4. Discussion

       In the present study, we demonstrated the beneficial effects of the folic acid on I/R injury. Treatment with folic acid significantly reduced the ALT and AST level increased by I/R and improved hepatocyte structure against I/R injury.

      Some evidence have associated low blood levels of folate with a greater risk of cancer [9]. Folate is involved in the synthesis, repair, and functioning of DNA and a deficiency of folate may result in damage to DNA that may lead to cancer [10]. Recognition of the ancillary actions of folic acid is important for understanding the agent's mechanisms of action and the pathologic mechanisms underlying I/R injury. Our previous study showed that folic acid increases DNA content and cytochrome P450 levels in ischemic/ reperfused liver, presumably as a result of inhibitory action of TNF-α by folic acid [11]. It was reported that portal triad clamping produces not only ischemic injury of the liver but also portal venous congestion [12]. Acute portal venous congestion for a long period may impair the intestinal mucosal barrier and increase intestinal permeability, causing endotoxemia, bacterial translocation, activation of reactive oxygen radicals and inflammatory cytokines, such as tumor necrosis factor-α [13-15]. Reperfusion of stagnant portal venous blood with deleterious chemical mediators into the ischemic liver aggravates the liver injury, leading to intra-abdominal sepsis and abscess formation, which is the major cause of postoperative septic complications induced by hepatic I/R injury [16, 17]. However, attempts to protect against hepatic I/R injury by alleviating the possible detrimental effects of portal venous congestion have not achieved satisfactory results. Hepatic injury caused by ischemia can be described as necrosis. It was reported that apoptosis of hepatocytes and sinusoidal endothelial cells is a critical mechanism contributing to hepatic I/R injury [8]. A number of genes regulate the apoptotic process. The family of bcl-2-related proteins plays a key role in the regulation of apoptosis. The bcl-2 gene, can promote cell survival through protein-protein interactions with other bcl-2-related protein family members. Recent studies indicated that overexpression of bcl-2 gene could reduce heptocellular apoptosisafter reperfusion and protect against hepatic I/R injury [18, 3]. Bcl-2 protein is a homodimer which inhibits cell death. Therefore, increased expression of bcl-2 may determine survival following apoptotic stimuli and attenuate the anti-apoptotic effect of bcl-2 gene by reducing post-ischemic apoptosis[19, 20]. In this study, upregulation of bcl-2 gene expression in rat liver were found after 1 h of ischemia and 3 h of reperfusion, indicating that folic acid can protect against hepatic apoptosis induced by I/R injury by regulating the expression of bcl-2 gene. In the present study, treatment with folic acid improved the degree of heptocellular structure. Although it is difficult to analyze the patho-physiological mechanism by which folic acid inhibits from I/R injury, our finding that the folic acid altered the expression levels of bcl-2 gene may provide a clue.


 Table 2. Effect of folic acid treatment on the apoptosis rates in liver cells after 1 h of ischemia and 3 h of reperfusion (TUNNEL assay).



       The authors are grateful to the Dr.R.M Dubey, Managing Director, IFTM for providing all help and facility to carry out the research work. The work was supported by grant from Institutional Research Promotional Scheme funded by IFTM, India.

[1]      Cory S, Huang DC, Adams JM. The Bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 2003; 22: 8590-607.


[2]      Mason RP, Campbell SF, Wang SD, Herbette LG. Comparison of location and binding for the positively charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes. Mol Pharmacol 1989; 36: 634-40.


[3]      Bilbao G, Contreras JL, Eckhoff DE, Mikheeva G, Krasnykh V, Douglas JT, Thomas FT, Thomas JM, Curiel DT. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg 1999; 230: 185-93.


[4]      Mattson MP, Shear TB. Folate and homocysteine metabolism in neural plasticity and neurodegen-erative disorders. Trends Neurosci 2003; 26: 137-46.


[5]      Kruman II, Kumaravel TS, Lohani A, Pederson WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002; 22:1752-62.


[6]      Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94: 3290-5.


[7]      Goulian M, Bleile B, Tseng B Y. Methotrexate-induced misincorporation of uracil into DNA.Proc Natl Acad Sci USA 1980; 77: 1956-60.


[8]      Hayashi H, Chaudhury IH, Chemens M, Bauue AB. Hepatic ischemia models for determine the effects of ATP MgCl2 treatment. J Surgical Res 1986; 40: 167-75.


[9]      Freudenheim JL, Grahm S, Marshall JR, Haughey BP, Cholewinski S, Wilkinson G. Folate intake and carcinogenesis of the colon and rectum. Internat J Epidemiol 1991; 20: 368-74.


[10]  Jennings E. Folic acid as a cancer preventing agent. Med Hypotheses 1995; 45: 297-303.


[11]  Chattopadhyay P, Sharma AK, Wahi AK. Folic acid protects hepatobiliary function in ischemic reperfusion of rat liver. Indian J Gastroenterol 2007; 26: 95-6.


[12]   Dai CL, Xia ZL, Kume M, Yamamoto Y, Yamagami K, Ozaki N, Yamaoka Y. Heat shock protein 72 normothermic ischemia, and the impact of congested portal blood reperfusion on rat liver.World J Gastroenterol 2001; 7: 415-8.


[13]  Ferri M, Gabriel S, Gavelli A, Franconeri P, Huguet C. Bacterial translocation during portal clamping for liver resection. A clinical study. Arch Surg 1997; 132: 162-5.


[14]  van Leeuwen PA, Hong RW, Rounds JD, Rodrick ML, Wilmore D. Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: The role of endotoxin. Surgery 1991; 110: 169-74.


[15]  Wang XD, Parsson H, Andersson R, Soltesz V, Johansson K, Bengmark S. Bacterial translocation, intestinal ultrastructure and cell membrane permeability early after major liver resection in the rat. Br J Surg 1994; 81: 579-84.


[16]   van As AB, Lotz Z, Tyler M, Kahn D. Reperfusion injury associated with portal venous and hepatic arterial perfusion in liver transplantation. Trans-plantation 2002; 74: 158-63.


[17]   Liu DL, Jeppsson B, Hakansson CH, Odselius R. Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg 1996; 131: 442-7.


[18]  Sun K, Liu ZS, Sun Q. Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic post-conditioning. World J Gastroenterol 2004; 10: 1934-8.

[19]  Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.

[20]  Bartling B, Holtz J, Darmer D. Contribution of myocyte apoptosis to myocardial infarction? Basic Res Cardiol 1998; 93: 71-84.